Corrigendum to “Cost-effectiveness of multigene sequencing test and treatment for metastatic non-small cell lung cancer: A unique setting in the initial adoption phase in Japan allowing testing only after standard treatment” [Heliyon Volume 10, Issue 19, October 2024, Article e37867]
Year: 2025
Type: erratum
Abstract: [This corrects the article DOI: 10.1016/j.heliyon.2024.e37867.].
Source: Heliyon
Authors: Naoko Shiraiwa, Shingo Kano
Institution: The University of Tokyo
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: gold
Estimated APC paid: $2,270
OpenAlex ID: W4416426643
Cites:
Cited by:
Related to: